Dihydromonacolin L
CAS : 86827-77-2
Ref. 3D-LDA82777
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander |
Informations sur le produit
- 2H-Pyran-2-one, tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-, (4R,6R)-
- 4a,5-Dihydromonacolin L
- (4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one
Dihydromonacolin L is a kinase inhibitor that has shown promise in the treatment of cancer. It is derived from Chinese medicinal herbs and has been found to induce apoptosis, or programmed cell death, in cancer cells. Dihydromonacolin L has been shown to be effective against a variety of tumors, including leukemia, by inhibiting the cell cycle and inducing apoptosis. This compound is an attractive target for anticancer drug development due to its potent inhibitory activity against protein kinases. In recent studies, it has been found that Dihydromonacolin L can enhance the anticancer effects of nintedanib, another cancer drug. Overall, Dihydromonacolin L shows great potential as a new class of anticancer agents with promising therapeutic applications.
Propriétés chimiques
Question d’ordre technique sur : 3D-LDA82777 Dihydromonacolin L
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages